Skip to main content
. 2023 Aug 24;9(9):e19386. doi: 10.1016/j.heliyon.2023.e19386

Table 1.

Baseline characteristics of patients who completed the trial (n [%], mean ± SD).

Characteristic TEAS group (n = 55) Sham-TEAS group (n = 55) P-value
Age (years) 70.09 ± 3.95 70.56 ± 4.59 0.69a
Race
 Han 54 (98.18%) 54 (98.18%)
 Other 1 (1.82%) 1 (1.82%)
Gender 0.18
 Female 20 (36.40%) 27 (49.10%)
 Male 35 (63.60%) 28 (50.90%)
BMI (kg/m2) 24.09 ± 2.78 23.63 ± 2.85 0.52a
Education 0.12
 <9 years 12 (21.80%) 13 (23.60%)
 9–12 years 36 (65.50%) 27 (49.10%)
 >12 years 7 (12.70%) 15 (27.30%)
Allergic history 8 (14.50%) 10 (18.20%) 0.61
Smoking history 23 (41.80%) 20 (36.40%) 0.56
Drinking history 5 (9.10%) 7 (12.70%) 0.54
Surgical history 33 (60.00%) 27 (49.10%) 0.25
Chronic diseases
 Hypertension 19 (34.50%) 22 (40.00%) 0.55
 Diabetes 6 (10.90%) 3 (5.50%) 0.49b
 Cardiopathy 3 (5.50%) 7 (12.70%) 0.19
MMSE Score 28.27 ± 1.22 28.07 ± 1.25 0.45a
MoCA Score 27.84 ± 1.21 27.86 ± 1.78 0.57a
NYHA 0.05
53 (96.40%) 47 (85.50%)
2 (3.60%) 8 (14.50%)

Abbreviations: BMI, body mass index; MMSE, Mini-Mental State Examination; MoCA, Montreal Cognitive Assessment; NYHA, New York Heart Association Functional Classification.

a

Indicates Mann-Whitney U test.

b

Indicates Fisher's exact test.